233 related articles for article (PubMed ID: 9480774)
1. Crystallographic structure of an intact IgG1 monoclonal antibody.
Harris LJ; Skaletsky E; McPherson A
J Mol Biol; 1998 Feb; 275(5):861-72. PubMed ID: 9480774
[TBL] [Abstract][Full Text] [Related]
2. Refined structure of an intact IgG2a monoclonal antibody.
Harris LJ; Larson SB; Hasel KW; McPherson A
Biochemistry; 1997 Feb; 36(7):1581-97. PubMed ID: 9048542
[TBL] [Abstract][Full Text] [Related]
3. The three-dimensional structure of an intact monoclonal antibody for canine lymphoma.
Harris LJ; Larson SB; Hasel KW; Day J; Greenwood A; McPherson A
Nature; 1992 Nov; 360(6402):369-72. PubMed ID: 1448155
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the conformations of two intact monoclonal antibodies with hinges.
Harris LJ; Larson SB; Skaletsky E; McPherson A
Immunol Rev; 1998 Jun; 163():35-43. PubMed ID: 9700500
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the disulfide-stabilized Fv fragment of anticancer antibody B1: conformational influence of an engineered disulfide bond.
Almog O; Benhar I; Vasmatzis G; Tordova M; Lee B; Pastan I; Gilliland GL
Proteins; 1998 May; 31(2):128-38. PubMed ID: 9593187
[TBL] [Abstract][Full Text] [Related]
6. Structure of the murine unglycosylated IgG1 Fc fragment.
Feige MJ; Nath S; Catharino SR; Weinfurtner D; Steinbacher S; Buchner J
J Mol Biol; 2009 Aug; 391(3):599-608. PubMed ID: 19559712
[TBL] [Abstract][Full Text] [Related]
7. Crystallization of intact monoclonal antibodies.
Harris LJ; Skaletsky E; McPherson A
Proteins; 1995 Oct; 23(2):285-9. PubMed ID: 8592710
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-gamma-interferon antibody.
Fan ZC; Shan L; Goldsteen BZ; Guddat LW; Thakur A; Landolfi NF; Co MS; Vasquez M; Queen C; Ramsland PA; Edmundson AB
J Mol Recognit; 1999; 12(1):19-32. PubMed ID: 10398393
[TBL] [Abstract][Full Text] [Related]
9. The Fab and Fc fragments of IgA1 exhibit a different arrangement from that in IgG: a study by X-ray and neutron solution scattering and homology modelling.
Boehm MK; Woof JM; Kerr MA; Perkins SJ
J Mol Biol; 1999 Mar; 286(5):1421-47. PubMed ID: 10064707
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional structures of a humanized anti-IFN-gamma Fab (HuZAF) in two crystal forms.
Bourne PC; Terzyan SS; Cloud G; Landolfi NF; Vásquez M; Edmundson AB
Acta Crystallogr D Biol Crystallogr; 2004 Oct; 60(Pt 10):1761-9. PubMed ID: 15388922
[TBL] [Abstract][Full Text] [Related]
11. Contrasting IgG structures reveal extreme asymmetry and flexibility.
Saphire EO; Stanfield RL; Crispin MD; Parren PW; Rudd PM; Dwek RA; Burton DR; Wilson IA
J Mol Biol; 2002 May; 319(1):9-18. PubMed ID: 12051932
[TBL] [Abstract][Full Text] [Related]
12. Crystallographic studies and primary structure of the antitumor monoclonal CC49 Fab'.
Abergel C; Padlan EA; Kashmiri SV; Milenic D; Calvo B; Schlom J
Proteins; 1993 Dec; 17(4):438-43. PubMed ID: 8108385
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for the binding of an anti-cytochrome c antibody to its antigen: crystal structures of FabE8-cytochrome c complex to 1.8 A resolution and FabE8 to 2.26 A resolution.
Mylvaganam SE; Paterson Y; Getzoff ED
J Mol Biol; 1998 Aug; 281(2):301-22. PubMed ID: 9698550
[TBL] [Abstract][Full Text] [Related]
14. Crystallographic analysis of the interaction between cyclosporin A and the Fab fragment of a monoclonal antibody.
Vix O; Rees B; Thierry JC; Altschuh D
Proteins; 1993 Apr; 15(4):339-48. PubMed ID: 8460105
[TBL] [Abstract][Full Text] [Related]
15. Extended flexible linker structures in the complement chimaeric conjugate CR2-Ig by scattering, analytical ultracentrifugation and constrained modelling: implications for function and therapy.
Gilbert HE; Aslam M; Guthridge JM; Holers VM; Perkins SJ
J Mol Biol; 2006 Feb; 356(2):397-412. PubMed ID: 16375923
[TBL] [Abstract][Full Text] [Related]
16. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition.
Calarese DA; Scanlan CN; Zwick MB; Deechongkit S; Mimura Y; Kunert R; Zhu P; Wormald MR; Stanfield RL; Roux KH; Kelly JW; Rudd PM; Dwek RA; Katinger H; Burton DR; Wilson IA
Science; 2003 Jun; 300(5628):2065-71. PubMed ID: 12829775
[TBL] [Abstract][Full Text] [Related]
17. GlnK, a PII-homologue: structure reveals ATP binding site and indicates how the T-loops may be involved in molecular recognition.
Xu Y; Cheah E; Carr PD; van Heeswijk WC; Westerhoff HV; Vasudevan SG; Ollis DL
J Mol Biol; 1998 Sep; 282(1):149-65. PubMed ID: 9733647
[TBL] [Abstract][Full Text] [Related]
18. Global structure of HIV-1 neutralizing antibody IgG1 b12 is asymmetric.
Ashish ; Solanki AK; Boone CD; Krueger JK
Biochem Biophys Res Commun; 2010 Jan; 391(1):947-51. PubMed ID: 19995532
[TBL] [Abstract][Full Text] [Related]
19. Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types.
Kanda Y; Yamada T; Mori K; Okazaki A; Inoue M; Kitajima-Miyama K; Kuni-Kamochi R; Nakano R; Yano K; Kakita S; Shitara K; Satoh M
Glycobiology; 2007 Jan; 17(1):104-18. PubMed ID: 17012310
[TBL] [Abstract][Full Text] [Related]
20. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
